Mylan’s Media Storm
August 25, 2016
Mylan introduces new schemes to help tackle EpiPen costs for patients, as well as plans for a new direct-to-patient distribution model
1 min read
False
Welcome to the July August issue. Upfront investigates how to make biopharma medicines on demand, a new method for targeting cancer, and the growth potential of China’s pharma market. In our cover feature, find out how the modern day cleanroom was invented and what new advances we might see in the future. Best Practice looks at how to use Six Sigma for Quality by Design, and NextGen celebrates the field of small-molecule drugs. We also sit down with Susanne Keitel, director of the EDQM.
August 25, 2016
Mylan introduces new schemes to help tackle EpiPen costs for patients, as well as plans for a new direct-to-patient distribution model
1 min read
August 23, 2016
Protection at the genetic level – a new line of defense against contamination in biopharmaceutical manufacturing
1 min read
August 17, 2016
The latest edition of the European Pharmacopoeia was published in July 2016 and some large changes are afoot. The industry is more globalized than ever before, and a greater range of international experts are being encouraged to get involved with setting and maintaining standards.
1 min read
August 17, 2016
Are you stuck at a Five Sigma improvement project? Or is Quality-by-Design based product development too cumbersome? Many people struggle with QbD, but there are secrets to success.
1 min read
August 17, 2016
Is innovation in small-molecule drugs dead? Certainly not – large molecules may grab the bulk of industry headlines, but small-molecule drugs are still pulling their weight. Ongoing research into improving small-molecule manufacturing is just as relevant in the age of biopharma.
1 min read
August 17, 2016
When it comes to oral drug delivery, tablets and capsules are often the “go-to” choice – but are you missing innovations in other areas as a result? The softgel is considered a good choice for poorly soluble molecules, and non-gelatin options are now broadening its reach.
1 min read
August 17, 2016
Sitting Down With… Susanne Keitel, Director of the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe in Strasbourg, France.
1 min read
August 17, 2016
Today’s cleanrooms may meet current quality standards, but what about the future? Opportunities for improvement can be found in all areas, from gowning to cleaning to implementing robotics technology.
1 min read
August 17, 2016
Cleanrooms are vital when it comes to ensuring that medicines are contamination free – and yet the technology behind them is well over 50 years old. Is it time for a makeover?
1 min read
August 17, 2016
Isn’t it time to move with the times and relegate manual and outdated processes?
1 min read
August 17, 2016
What began 56 years ago as a vision of miniaturization is now beginning to have a profound influence on drug delivery.
1 min read
August 17, 2016
Is leaving the EU a foolish or admirable decision? The UK still has a way to go before the shape of Brexit becomes clear, but the pharma industry can succeed if the right policies are put in place.
1 min read
August 17, 2016
Researchers call for more oversight as some pharma companies cozy up to hemophilia patients
1 min read
August 17, 2016
Can portable kits manufacture on-demand biopharma medicines for remote soldiers?
1 min read
August 17, 2016
A website exists to help researchers obtain clinical study data, but how useful is it?
1 min read
August 17, 2016
First, zap the tumor with radiation to trigger P-selectin expression. Second, release a targeted attack of drug-loaded nanoparticles
1 min read
August 17, 2016
The world’s most populous state is set for big things in patented (bio) pharmaceutical development, according to a new report
1 min read
August 17, 2016
In addition to learning from our own mistakes, we should look to Warning Letters – and the subsequent solutions – to benefit from the blunders of others.
1 min read
False
False
False